Eton Pharmaceuticals Inc. (ETON) Live Share Price, Invest From India

Eton Pharmaceuticals Inc. Stock Performance

as on June 30, 2026 at 6:59 am IST

Day's Low
Day's High
$34.85
Day's Price Range
$36.95
$36.74
5.14%
Downside
0.57%
Upside
52 Week's Low
52 Week's High
$13.51
52-Week Price Range
$35.99
$36.74
63.23%
Downside
-2.04%
Upside

Eton Pharmaceuticals Inc. share price movements today

Previous Close: $35.70
Open: $35.66
Volume: 774.3K
Day's Low - High: $34.85 - $36.95
52 Week Low - High: $13.51 - $35.99

Eton Pharmaceuticals Inc. Historical Returns

1 Month Return: + 17.24 %
3 Month Return: + 53.61 %
1 Year Return: + 154.82 %
3 Year Return: 0 %
5 Year Return: 0 %

Eton Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Eton Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$977.9M

EPS (TTM)

1.01

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.13%

PE Ratio (TTM)

PEG Ratio

EBITDA

11.1M

Revenue (TTM)

86.9M

Profit Margin

-1.70%

Return On Equity TTM

-5.36%

Eton Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eton Pharmaceuticals Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Eton Pharmaceuticals Inc.	BUY	$977.9M	NA	NA	-1.70%	NA
United Therapeutics Corporation	BUY	$23.0B	206.59%	20.05	40.62%	NA
Viatris Inc.	HOLD	$19.0B	12.47%	NA	-2.04%	2.9899999999999998%
Haleon plc (ADR)	BUY	$40.7B	NA	18.86	15.11%	2.09%
ZOETIS INC.	BUY	$31.9B	-59.52%	12.47	28.04%	2.6100000000000003%

See all

Stock Returns calculator for Eton Pharmaceuticals Inc. Stock including INR - Dollar returns

The Eton Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Eton Pharmaceuticals Inc. investment value today

Current value as on today

₹2,89,292

Returns

₹1,89,292

(+189.29%)

Returns from Eton Pharmaceuticals Inc. Stock

₹1,62,241 (+162.24%)

Dollar Impact

₹27,050 (+27.05%)

Analyst Recommendation on Eton Pharmaceuticals Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Eton Pharmaceuticals Inc.. Average target price of $45.67

Eton Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Eton Pharmaceuticals Inc..

What analysts predicted

19.55%UPSIDE

Target Price

$45.67

Current Price

$36.74

Analyzed by

7 Analysts

Target

$45.67

Eton Pharmaceuticals Inc. target price $45.67, a slight upside of 19.55% compared to current price of $36.74. According to 7 analysts rating.

Indian Investors' Interest in Eton Pharmaceuticals Inc. Stock

Search interest for Eton Pharmaceuticals Inc. Stock has increased by 139% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 31, 2026 to June 30, 2026

Change:139% versus previous 30 day period

Eton Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	7	7	9	10	11	17	18	22	21	24
Gross Profit	3	5	5	6	6	9	11	7	13	14
Operating Income	-1	0	-2	0	0	0	-1	-1	2	2
EBITDA	-2	0	-2	0	0	0	0	0	3	1
Interest Expense	0	0	0	0	1	1	1	1	1	0
Depreciation	0	0	0	0	0	1	1	1	1	1
Income Before Tax	-2	0	-2	0	0	-1	-2	-1	1	1
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-2	0	-3	0	0	-1	-2	-1	1	1
Net Profit Margin	-30.85%	-10.18%	-33.51%	6.07%	-5.13%	-9.10%	-13.66%	-8.58%	6.97%	6.40%

Eton Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	0	0	21	21	31	39	79
Gross Profit	0	0	0	0	19	14	21	23	42
Operating Income	-7	-10	-18	-27	-1	-8	-1	-2	0
EBITDA	-7	-10	-18	-26	-1	-7	0	0	4
Interest Expense	-	0	0	0	1	0	1	2	4
Depreciation	-	0	0	0	0	1	0	1	4
Income Before Tax	-7	-12	-18	-27	-1	-9	0	-3	-4
Income Tax Expense	-	-2	0	0	1	0	0	0	0
Net Income	-7	-12	-18	-27	-1	-9	0	-3	-4
Net Profit Margin	0.00%	0.00%	-1910.32%	-71717.95%	-8.95%	-42.45%	-2.96%	-9.80%	-5.75%

Eton Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	0	-3	0	0	-1	-2	-1	1	1
Operating Cash Flow	-2	1	2	0	2	7	12	-11	7
Investing Cash Flow	-1	-	1	-38	-	-	0	0	-15
Financing Cash Flow	0	0	0	33	0	-	-	0	1
Change in Cash	-4	1	2	-5	2	7	11	-11	-6

Eton Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-12	-18	-27	-1	-9	0	-3	-4
Operating Cash Flow	-8	-18	-22	-4	4	6	0	10
Investing Cash Flow	0	-1	0	-2	-2	0	-40	0
Financing Cash Flow	21	5	31	0	0	0	32	0
Change in Cash	13	-14	9	-6	1	5	-6	11

Global Institutional Holdings in Eton Pharmaceuticals Inc.

Funds	Holdings
Vanguard Capital Management, LLC	3.63%
Renaissance Technologies Corp	0.75%
State Street Corp	1.94%
Woodline Partners LP	0.62%
Lumbard Investment Counseling LLC	0.64%

See all

Insights on Eton Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 21.28M → 24.26M (in $), with an average increase of 12.3% per quarter
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ETON has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, -2.58M → 1.55M (in $), with an average increase of 89.6% per quarter
POSITIVE IMPACT
Price Rise
In the last 1 month, ETON stock has moved up by 17.2%

About Eton Pharmaceuticals Inc.

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Organisation	Eton Pharmaceuticals Inc.
Headquarters	21925 W. Field Parkway, Deer Park, IL, United States, 60010-7278
Industry	Drug Manufacturers - Specialty & Generic
CEO	Mr. Sean E. Brynjelsen
E-voting on shares	Click here to vote

Key Management of Eton Pharmaceuticals Inc.

Name	Title
Mr. James R. Gruber CPA	Consultant
Ms. Ipek Erdogan-Trinkaus	Chief Commercial Officer
Ms. Judith M. Matthews	Chief Financial Officer
Danka Radosavljevic	Executive Vice President of Operations
Mr. Scott Grossenbach	Senior Vice President of Sales Operations
Mr. Sean E. Brynjelsen	President, CEO & Director
Mr. David C. Krempa	Chief Business Officer

FAQs

What is Eton Pharmaceuticals Inc. share price today?

Eton Pharmaceuticals Inc. share price today is $36.74 as on June 30, 2026 at 1:29 am IST at the close of the market. Eton Pharmaceuticals Inc. share today touched a day high of $36.95 and a low of $34.85.

What is the 52 week high and 52 week low for Eton Pharmaceuticals Inc. share?

Eton Pharmaceuticals Inc. share touched a 52 week high of $35.99 on June 26, 2026 and a 52 week low of $13.51 on July 1, 2025. Eton Pharmaceuticals Inc. stock price today i.e. June 30, 2026 at 1:29 am IST is closed at $36.74,which is -2.08% down from its 52 week high and 171.95% up from its 52 week low.

What is Eton Pharmaceuticals Inc.'s market capitalisation today?

Eton Pharmaceuticals Inc. market capitalisation is $0.00T as on June 30, 2026 at 1:29 am IST.

How to invest in Eton Pharmaceuticals Inc. Stock (ETON) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Eton Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eton Pharmaceuticals Inc. Shares that will get you 0.0408 shares as per Eton Pharmaceuticals Inc. share price of $36.74 per share as on June 30, 2026 at 1:29 am IST.

What is the minimum amount required to buy Eton Pharmaceuticals Inc. Stock (ETON) from India?

Indian investors can start investing in Eton Pharmaceuticals Inc. (ETON) shares with as little as ₹94.54 or $1 (as of June 30, 2026 at 3:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹945.40 in Eton Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on June 30, 2026 at 3:41 am IST). Based on Eton Pharmaceuticals Inc. share’s latest price of $36.74 as on June 30, 2026 at 1:29 am IST, you will get 0.2722 shares of Eton Pharmaceuticals Inc.. Learn more about fractional shares .